[{"AccountsPayableCurrent_0_Q2_USD":6339000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":11637000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":5417000.0,"OtherLiabilitiesCurrent_0_Q2_USD":4027000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-7375000.0,"ProceedsFromSaleOfMachineryAndEquipment_2_Q2_USD":14000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":191000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":489697000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":9886000.0,"PreferredStockNoParValue_0_Q2_USD":0.0001,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-511000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-61220000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-24083000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1037100000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":729000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-12439000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":350000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":203682000.0,"OtherAssetsNoncurrent_0_Q2_USD":3891000.0,"NonoperatingIncomeExpense_2_Q2_USD":16660000.0,"NonoperatingIncomeExpense_1_Q2_USD":7767000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":429000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":14509000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":7175000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":4179000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":609000.0,"MarketableSecurities_0_Q2_USD":598720000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5417000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":10749000.0,"ReceivablesNetCurrent_0_Q2_USD":1865000.0,"ProceedsFromStockPlans_2_Q2_USD":350000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":66384000.0,"OtherNoncashIncomeExpense_2_Q2_USD":289000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":76000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":-511000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":28569000.0,"OperatingLeasePayments_2_Q2_USD":5125000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":22153000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":6650000.0,"InvestmentIncomeNet_2_Q2_USD":2151000.0,"InvestmentIncomeNet_1_Q2_USD":592000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-93000.0,"EquitySecuritiesFvNiUnrealizedGain_2_Q2_USD":14525000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_2_Q2_USD":0.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_2_Q2_USD":60000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":7883000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":3066000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":138406000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":40940000.0,"ContractWithCustomerLiability_0_Q2_USD":179346000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":249895000.0,"MarketableSecuritiesCurrent_0_Q2_USD":112901000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":16472000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":21741000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":8846000.0,"NetIncomeLoss_2_Q2_USD":-61296000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-84942000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":120637000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":214200000.0,"LiabilitiesCurrent_0_Q2_USD":68150000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":655481000.0,"Liabilities_0_Q2_USD":228709000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":3254000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":1447000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1026000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":31852000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":14081000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.12,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.43,"Depreciation_2_Q2_USD":1669000.0,"CommonStockValue_0_Q2_USD":6000.0,"CommonStockSharesOutstanding_0_Q2_shares":62103649.0,"CommonStockSharesIssued_0_Q2_shares":62265649.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":485819000.0,"AssetsCurrent_0_Q2_USD":610126000.0,"Assets_0_Q2_USD":655481000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":4495856.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":183000.0,"NetIncomeLoss_1_Q2_USD":-23572000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":1344000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":3993000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":203964000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":6839000.0,"StockIssuedDuringPeriodSharesNewIssues_0_Q2_shares":6900000.0,"ShareBasedCompensation_2_Q2_USD":11637000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":62576000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":28007000.0,"PreferredStockValue_0_Q2_USD":null,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"OperatingIncomeLoss_2_Q2_USD":-77956000.0,"OperatingIncomeLoss_1_Q2_USD":-31339000.0,"OperatingExpenses_2_Q2_USD":94428000.0,"OperatingExpenses_1_Q2_USD":42088000.0,"CommonStockSharesAuthorized_0_Q2_shares":195000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"AccruedLiabilitiesCurrent_0_Q2_USD":10194000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":54968123.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":55346052.0,"StockholdersEquity_0_Q2_USD":426772000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-610517000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":12895000.0,"ProfitLoss_2_Q2_USD":-61296000.0,"ProceedsFromIssuanceOfCommonStock_0_Q2_USD":203700000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":9541000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":3319000.0,"Ticker":"EDIT","CIK":"1650664","name":"EDITAS MEDICINE, INC.","OfficialName":"Editas Medicine Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1081229362.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200807"}]